|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.332
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.211
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.173
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.145
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.138
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.127
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.099
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.096
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.095
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.095
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.091
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.084
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.077
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.073
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.070
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.066
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.065
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.063
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.062
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.061
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.060
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.060
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.057
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.056
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.053
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.053
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.052
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.052
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.050
|
|
|
|
metanephric glomerular visceral epithelial cell development
|
GO:0072249 |
2 |
0.050
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.050
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.048
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.048
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.047
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.046
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.046
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.045
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.045
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.044
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.043
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.043
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.043
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.042
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.041
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.040
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.039
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.039
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.039
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.039
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.039
|
|
|
|
sodium ion export
|
GO:0071436 |
2 |
0.039
|
|
|
|
glomerular basement membrane development
|
GO:0032836 |
8 |
0.039
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.038
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.038
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.038
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.038
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.038
|
|
|
|
relaxation of smooth muscle
|
GO:0044557 |
8 |
0.038
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.037
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.037
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.036
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.036
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.036
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.036
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.035
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.035
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.035
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.035
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.034
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.033
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.033
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.033
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.033
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.033
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.032
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.032
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.031
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.030
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.030
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.030
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.029
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.029
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.028
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.028
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.028
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.027
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.027
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.027
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.027
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.027
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.026
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.026
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.025
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.025
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.025
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.024
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.024
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.024
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.024
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.023
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.023
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.023
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.023
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.023
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.023
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.023
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.022
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.022
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.022
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.022
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.022
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.021
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.021
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.021
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.021
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.021
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.021
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.021
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
response to symbiont
|
GO:0009608 |
2 |
0.020
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.020
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.020
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.020
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.019
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.019
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.019
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.019
|
|
|
|
metanephric glomerular epithelial cell differentiation
|
GO:0072312 |
2 |
0.019
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.019
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.019
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.019
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.019
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.019
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.019
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.019
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.019
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.018
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.018
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.018
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.018
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.018
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.018
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.018
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.018
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.018
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.018
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.018
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.017
|
|
|
|
positive regulation of extracellular matrix organization
|
GO:1903055 |
4 |
0.017
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.017
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.017
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.017
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.017
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.017
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.017
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.017
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.017
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.017
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.017
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.017
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.017
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.016
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.016
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.016
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.016
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.016
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.016
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.016
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.016
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.016
|
|
|
|
protein localization to synapse
|
GO:0035418 |
11 |
0.016
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.016
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.016
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.016
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.016
|
|
|
|
transcription initiation from rna polymerase i promoter
|
GO:0006361 |
4 |
0.016
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.016
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.016
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.016
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.016
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.016
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.016
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.016
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.016
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.016
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.016
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.015
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.015
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.015
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.015
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.015
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.015
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.015
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.015
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.015
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.015
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
7 |
0.015
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.015
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.015
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.015
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.015
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.015
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.015
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.015
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.014
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.014
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.014
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.014
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.014
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.014
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.014
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.014
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.014
|
|
|
|
negative regulation of fatty acid transport
|
GO:2000192 |
1 |
0.014
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.014
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.014
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.014
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.014
|
|
|
|
relaxation of vascular smooth muscle
|
GO:0060087 |
7 |
0.014
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.014
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.014
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.014
|
|
|
|
negative regulation of potassium ion transmembrane transporter activity
|
GO:1901017 |
3 |
0.014
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.014
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.014
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.013
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.013
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.013
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.013
|
|
|
|
glomerular epithelial cell development
|
GO:0072310 |
6 |
0.013
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.013
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.013
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.013
|
|
|
|
cell differentiation involved in metanephros development
|
GO:0072202 |
12 |
0.013
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.013
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.013
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.013
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.013
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.013
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.013
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.013
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.013
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.013
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.013
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.013
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.013
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.013
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.013
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.013
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.013
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.013
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.013
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.013
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.013
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.013
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.013
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.013
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.013
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.013
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.013
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.013
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.012
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.012
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.012
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.012
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.012
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.012
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.012
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.012
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.012
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.012
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.012
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.012
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.012
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.012
|
|
|
|
glomerular visceral epithelial cell differentiation
|
GO:0072112 |
10 |
0.012
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.012
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.012
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.012
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.012
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.012
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.012
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.011
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.011
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.011
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.011
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.011
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.011
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.011
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.011
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.011
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.011
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.011
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.011
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.011
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.011
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.011
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.011
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.011
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.011
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.011
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.011
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.011
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.011
|
|
|
|
renal filtration cell differentiation
|
GO:0061318 |
10 |
0.011
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.011
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.010
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.010
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.010
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.010
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.010
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.010
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.010
|
|
|
|
cgmp mediated signaling
|
GO:0019934 |
3 |
0.010
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.010
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.010
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.010
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.010
|
|
|
|
metanephric glomerular basement membrane development
|
GO:0072274 |
1 |
0.010
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.010
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.010
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.010
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.010
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.010
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.010
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.010
|
|